Totally disagree with your value. To begin with fv(fair value) in an emerging market with the growth we are experiencing should be 10x sales or more. With $9.4 Mil forecasted that gives us almost $100Mil market cap or close to $4.00 per share.
BTW/FWIW To get this valuation with regards to sales forcast I will lean towards WW verses your simple math of extrapolating your $1.5 Mil Q1.
You are sometimes so obvious when you want cheap shares venting on O/S shares and not including forward thinking(new labs+opportunities). Not to mention the pontificating of your trading expertise buying the lows and selling at the highs.